IN8bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IN8bio and other ETFs, options, and stocks.About INAB
IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S.
CEOWilliam T. Ho
CEOWilliam T. Ho
Employees18
Employees18
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2016
Founded2016
Employees18
Employees18
INAB Key Statistics
Market cap13.46M
Market cap13.46M
Price-Earnings ratio-0.30
Price-Earnings ratio-0.30
Dividend yield—
Dividend yield—
Average volume9.68M
Average volume9.68M
High today$0.1555
High today$0.1555
Low today$0.1269
Low today$0.1269
Open price$0.1404
Open price$0.1404
Volume50.72M
Volume50.72M
52 Week high$1.74
52 Week high$1.74
52 Week low$0.112
52 Week low$0.112
People also own
Based on the portfolios of people who own INAB. This list is generated using Robinhood data, and it’s not a recommendation.